7Baggers
 can-fite biopharma reports h1 2025 results and updates  TipRanks Wed, 24 Sep 2025 04:07:39 GMT
 published on: 2025-09-19 10:51:11  خودرو بانک Fri, 19 Sep 2025 07:24:38 GMT
 published on: 2025-09-18 13:31:58  newser.com Thu, 18 Sep 2025 18:31:58 GMT
 published on: 2025-09-15 14:14:37  newser.com Mon, 15 Sep 2025 19:14:37 GMT
 can-fite biopharma announces new findings for namodenoson  TipRanks Mon, 15 Sep 2025 11:50:47 GMT
 Can-Fite Reports Complete Resolution of Esophageal Varices  GlobeNewswire Mon, 15 Sep 2025 07:00:00 GMT
 published on: 2025-09-09 05:38:26  Newser Tue, 09 Sep 2025 10:38:26 GMT
 published on: 2025-09-08 01:32:26  Newser Mon, 08 Sep 2025 06:32:26 GMT
 published on: 2025-09-05 10:18:22  beatles.ru Fri, 05 Sep 2025 07:19:25 GMT
 can-fite biopharma (nyse:canf) given buy rating at d. boral capital  Defense World Wed, 03 Sep 2025 06:05:04 GMT

Can-Fite BioPharma Ltd
(NYSE MKT:CANF) 

CANF stock logo

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, COVID-19 and erectile dysfunction. The company's lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical tri...

Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends